Biomarkers for psychiatric disorders: Where are we standing?

Disease Markers

Volumn 35, Issue 1, 2013, Pages 1-2

  Martins De Souza, Daniel ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BIPOLAR DISORDER; DEPRESSION; DIAGNOSTIC TEST; EDITORIAL; HUMAN; MENTAL DISEASE; METABOLIC DISORDER; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

BIOLOGICAL MARKERS; HUMANS; MENTAL DISORDERS;

EID: 84883102035     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/321071     Document Type: Editorial

References (8)

1. A. Gonzalez-Pinto, M. Gutierrez, F. Mosquera et al., "First episode in bipolar disorder: misdiagnosis and psychotic symptoms," Journal for Affective Disorders, vol. 50, no. 1, pp. 41-44, 1998.
2. J. C. Wakefield, "Misdiagnosing normality: psychiatry's failure to address the problem for false positive diagnoses for mental disorder in a changing professional environment," Journal for Mental Health, vol. 19, no. 4, pp. 337-351, 2010.
3. E. Schwarz, R. Izmailov, M. Spain et al., "Validation for a blood-based laboratory test to aid in the confirmation for a diagnosis for schizophrenia," Biomarker Insights, vol. 2010, no. 5, pp. 39-47, 2010.
4. D. Martins-de-Souza, "Translational strategies to schizophrenia from a proteomic perspective," Translational Neuroscience, vol. 3, no. 3, pp. 300-302, 2012.
5. A. G. Cardno and I. I. Gottesman, "Twin studies for schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics," American Journal for Medical Genetics, vol. 97, no. 1, pp. 12-17, 2000.
6. O. D. Howes, C. McDonald, M. Cannon, L. Arseneault, J. Boydell, and R. M. Murray, "Pathways to schizophrenia: the impact for environmental factors," International Journal for Neuropsychopharmacology, vol. 7, supplement 1, pp. S7-S13, 2004.
7. D. Martins-de-Souza, "Is the word 'biomarker' being properly used by proteomics research in neuroscience?" The European Archives for Psychiatry and Clinical Neuroscience, vol. 260, no. 7, pp. 561-562, 2010.
8. S. Bahn, E. Schwarz, L. W. Harris, D. Martins-de-Souza et al., "Biomarker blood tests for diagnosis and management for mental disorders: focus on schizophrenia," Revista de Psiquiatria Clínica, vol. 40, no. 1, article 7, 2013.